Optimisation of Care in Vulnerable HIV Infected Individuals

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

June 15, 2022

Study Completion Date

December 15, 2023

Conditions
HIV Infections
Interventions
OTHER

Opticare study

"Each patient will be evaluated by~* An HIV physician~* A nurse~* A social worker~* A psychological therapist~* A cultural mediator/member of patients community if needed for migrants~Following these interviews and visits, a multisciplinary team will define for each patient an individualized OPTICARE program based on the following items: clinical, psychological/psychiatric, social status and follow up visits will be planned with the patient.~Regular (Day 15 and monthly) phone calls will be set up during the first six months of the OPTICARE program, to assess the clinical status and ART adherence.~Patients will have their medical, biological and social status assessed through visits at W4, W12, W24, W36 (medical and social status only) and W 48 with all members of the OPTICARE team."

Trial Locations (1)

75013

Yasmine Dudoit, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ViiV Healthcare

INDUSTRY

collaborator

Institut de Sante Publique, d'Epidemiologie et de Developpement

OTHER

lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER

NCT03799276 - Optimisation of Care in Vulnerable HIV Infected Individuals | Biotech Hunter | Biotech Hunter